The International Society of Glomerular Disease: Building the Future of Glomerular Medicine

Laurel J Damashek; Sharon G Adler; Joshua M Tarnoff; Tobias B Huber

doi:10.1159/000534536

The International Society of Glomerular Disease: Building the Future of Glomerular Medicine

Glomerular Dis. 2023 Oct 10;3(1):230-232. doi: 10.1159/000534536. eCollection 2023 Jan-Dec.

Authors

Laurel J Damashek¹, Sharon G Adler^{2

3}, Joshua M Tarnoff⁴, Tobias B Huber⁵

Affiliations

¹ Executive Director, International Society of Glomerular Disease (ISGD), Florence, MA, USA.
² Lundquist Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
³ David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
⁴ NephCure, King of Prussia, PA, USA.
⁵ III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

No abstract available

Keywords: Collaboration; Glomerular medicine; Medical societies; Patient access.

Publication types

Editorial

Grants and funding

The International Society of Glomerular Disease has received financial support from Travere Therapeutics, Boehringer Ingelheim, and Chinook Therapeutics, and in-kind support from NephCure and the International Podocyte Conference. These bodies had no role in the preparation of the manuscript.